UK'S MHRA: APPROVES TEPROTUMUMAB AS FIRST UK TREATMENT FOR ADULTS WITH MODERATE TO SEVERE THYROID EYE DISEASE

Reuters · 05/07/2025 16:19

Please log in to view news